You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Details for New Drug Application (NDA): 201277

✉ Email this page to a colleague

« Back to Dashboard

NDA 201277 describes GADAVIST, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the GADAVIST profile page.

The generic ingredient in GADAVIST is gadobutrol. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the gadobutrol profile page.

Summary for 201277

Tradename:	GADAVIST
Applicant:	Bayer Hlthcare
Ingredient:	gadobutrol
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 201277

Mechanism of Action	Magnetic Resonance Contrast Activity

Suppliers and Packaging for NDA: 201277

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277	NDA	Bayer HealthCare Pharmaceuticals Inc.	50419-325	50419-325-14	2 CARTON in 1 BOX (50419-325-14) / 5 BOTTLE, GLASS in 1 CARTON / 30 mL in 1 BOTTLE, GLASS
GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277	NDA	Bayer HealthCare Pharmaceuticals Inc.	50419-325	50419-325-15	10 BOTTLE, GLASS in 1 BOX (50419-325-15) / 65 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	4.5354GM/7.5ML (604.72MG/ML)
Approval Date:	Mar 14, 2011	TE:	AP	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	6.0472GM/10ML (604.72MG/ML)
Approval Date:	Mar 14, 2011	TE:	AP	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	9.0708GM/15ML (604.72MG/ML)
Approval Date:	Mar 14, 2011	TE:	AP	RLD:	Yes

Expired US Patents for NDA 201277

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-002	Mar 14, 2011	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-003	Mar 14, 2011	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-004	Mar 14, 2011	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-006	Dec 18, 2013	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-005	Mar 14, 2011	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	GADAVIST	gadobutrol	SOLUTION;INTRAVENOUS	201277-001	Mar 14, 2011	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.